Literature DB >> 22126541

Effects of yiqi chutan tang on the proteome in Lewis lung cancer in mice.

Shumei Wang1, Lizhu Lin, Jinxu Zhou, Shaoquan Xiong, Daihan Zhou.   

Abstract

In order to verify effects of yiqi chutan tang on lung cancer and assess molecular mechanisms involved we focused on size, tumor weight and the numbers of lung metastases and differential expression protein spot information acquired by two-way fluorescence with a tumor difference gel electrophoresis (2D-DIGE) system, and differentially expressed proteins were identified by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-TOF). Differences were finally verified by Western blot and fluorescence quantitative PCR. We found that tumor size, tumor weight in yiqi chutan tang treatment group were significantly less than that in model group (p<0.01), with a tumor growth inhibition rate of 57.2%. For gel diagram analysis of 2D-DIGE system, compared with model group, there were 44 expressed differentially protein spots, of which 6 were up-regulated and 38 were down-regulated. Among these proteins, 37 (30 down-regulated and 7 up-regulated) were successfully identified by MALDI-TOF-TOF. In conclusion, yiqi chutan tang effects on Lewis lung cancer appeared highly related to down-regulated expression of Hspd1, prolyl 4-hydroxylase, protein disulfide-isomerase A3 precursor, EG433182, heat shock protein 5 precursor, heat shock protein 9 and stress-induced phosphoprotein 1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126541

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines.

Authors:  Shu-mei Wang; Li-zhu Lin; Dai-han Zhou; Jing-xu Zhou; Shao-quan Xiong
Journal:  Chin J Integr Med       Date:  2014-01-02       Impact factor: 1.978

Review 2.  Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine.

Authors:  Yulin Zhang; Yeer Liang; Chengwei He
Journal:  Chin Med       Date:  2017-07-12       Impact factor: 5.455

3.  iTRAQ-Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha-1-Antitrypsin as Potential Biomarkers.

Authors:  Yu Yang; Junmeng Wei; Xuekuan Huang; Mingjun Wu; Zhenbing Lv; Pan Tong; Rui Chang
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-27       Impact factor: 2.629

4.  Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data.

Authors:  Lingling Sun; Wan Sze Yim; Paul Fahey; Shutang Wang; Xiaoshu Zhu; Jing Qiao; Hezheng Lai; Lizhu Lin
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-02       Impact factor: 2.629

5.  Yiqi Chutan Tang Reduces Gefitinib-Induced Drug Resistance in Non-Small-Cell Lung Cancer by Targeting Apoptosis and Autophagy.

Authors:  Jue Zhang; Lingling Sun; Jian Cui; Jing Wang; Xiaomin Liu; Thazin Nwe Aung; Zhipeng Qu; Zhuangzhong Chen; David L Adelson; Lizhu Lin
Journal:  Cytometry A       Date:  2019-08-14       Impact factor: 4.355

6.  Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer.

Authors:  Jeffrey D White; Hongsheng Lin; Libin Jia; Roy S Wu; Stephen Lam; Jie Li; Jinhui Dou; Nagi Kumar; Lizhu Lin; Lixing Lao
Journal:  J Glob Oncol       Date:  2016-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.